Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4/A Grant or award Director acquired 2,945 shares (grant or award)
  2. 4 Planned sale General Counsel sold 2,000 shares at $38.47 ($76,940)
  3. 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at an average $39.06 ($650,952)
  4. 4 Grant or award Director acquired 4,800 shares (grant or award)
  5. 4 Grant or award Director acquired 4,800 shares (grant or award)
  6. 4 Grant or award Director acquired 4,800 shares (grant or award)
  7. 4 Grant or award Director acquired 4,800 shares (grant or award)
  8. 4 Grant or award Director acquired 4,800 shares (grant or award)
  9. 4 Grant or award Director acquired 4,800 shares (grant or award)
  10. 4 Grant or award Director acquired 4,800 shares (grant or award)
  11. 4 Planned sale GOLDSMITH MARK A sold 11,950 shares at $37.39 ($446,770)
  12. 4 Planned sale Chief Financial Officer sold 1,893 shares at $37.39 ($70,775)
  13. 4 Planned sale Chief Operating Officer sold 4,415 shares at $37.39 ($165,064)
  14. 4 Planned sale Kelsey Stephen Michael sold 3,349 shares at $37.39 ($125,209)
  15. 4 Planned sale General Counsel sold 1,757 shares at $37.39 ($65,690)
  16. 4 Open-market sale Chief Medical Officer sold 5,589 shares at $37.39 ($208,954)
  17. 4 Planned sale GOLDSMITH MARK A sold 7,500 shares at an average $39.99 ($299,942)
  18. 4 Planned sale General Counsel sold 1,500 shares at an average $39.11 ($58,671)
  19. 4 Planned sale Chief Financial Officer sold 10,000 shares at $40.03 ($400,260)
  20. 4 Planned sale GOLDSMITH MARK A sold 17,500 shares at an average $35.40 ($619,467)

Page 9 of 21 · 414 filings